Active, Not Recruiting
A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies
NCT05428969
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +17 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
- University of Texas, MD Anderson Cancer Center Houston, Texas, United States